Latest Period
Q1 2026
Security Snapshot
Jasper Therapeutics, Inc. - Voting Common Stock (JSPR) Institutional Ownership
CUSIP: 471871202
13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026
Institutions Reporting
57
Shares (Excl. Options)
15,813,140
Price
$0.88
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Voting Common Stock
- Symbol
- JSPR on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 15,813,140
- Total 13F value
- $13,860,993
- Portfolio coverage rank
- 0%
- Share change
- -3,407,594
- Value change
- -$7,106,029
- Number of holders
- 57
- Shares outstanding
- 27,779,583
- SEC-reported price per share
- $0.91
- Insider filing price
- $0.91
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- JSPR - Jasper Therapeutics, Inc. - Voting Common Stock is tracked under CUSIP 471871202.
- 57 institutions reported positions in Q1 2026.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 53 to 57 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $35,163,686 to $13,860,993.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 57 institutions filings for Q1 2026.
Security key
471871202
Latest holder period
Q1 2026
13F holders
57
13D/G owners
11
CIK / CUSIP context first
Open Q1 2026 holders
JSPR full holder history
Jasper Therapeutics, Inc. SEC filings
Jasper Therapeutics, Inc. company facts
Jasper Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 471871202:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
JSPR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Velan Capital Investment Management LP | 9.6% | $7,578,242 | 2,668,395 | Velan Capital Investment Management LP | 19 Sep 2025 | |||
| T. Rowe Price Investment Management, Inc. | 7.1% | $4,897,117 | 2,057,612 | T. Rowe Price Investment Management, Inc. | 30 Sep 2025 | |||
| INTEGRATED CORE STRATEGIES (US) LLC | 5.8% | $2,492,390 | 1,629,013 | Millennium Management LLC | 18 Feb 2026 | |||
| ACORN BIOVENTURES, L.P. | 5.3% | -18% | $2,660,821 | -$537,000 | 1,486,492 | -17% | Anders Hove | 23 Jan 2026 |
| MORGAN STANLEY | 4.8% | -31% | $1,226,746 | -$585,456 | 1,333,420 | -32% | Morgan Stanley | 31 Mar 2026 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4.7% | -8% | $3,153,131 | +$1,332,431 | 1,324,845 | +73% | Kingdon Capital Management, L.L.C. | 30 Sep 2025 |
| Carlyle Group Inc. | 3.8% | $1,665,114 | 1,088,310 | The Carlyle Group Inc. | 18 Feb 2026 | |||
| Qiming U.S. Healthcare Fund II, L.P. | 3.3% | $2,210,934 | 928,964 | Qiming U.S. Healthcare Fund II, L.P. | 30 Sep 2025 | |||
| Soleus Capital Master Fund, L.P. | 1% | -90% | $254,207 | -$1,120,659 | 276,312 | -82% | Soleus Capital Management, L.P. | 31 Mar 2026 |
| BlackRock, Inc. | 1.5% | $1,252,311 | 225,605 | BlackRock, Inc. | 30 Jun 2025 | |||
| GOLDMAN SACHS GROUP INC | 0.5% | -97% | $118,553 | -$1,505,107 | 128,862 | -93% | THE GOLDMAN SACHS GROUP, INC. | 31 Mar 2026 |
As of 31 Mar 2026, 57 institutional investors reported holding 15,813,140 shares of Jasper Therapeutics, Inc. - Voting Common Stock (JSPR). This represents 57% of the company’s total 27,779,583 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
55%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Velan Capital Investment Management LP | 9.6% | 2,668,395 | 0% | 1.5% | $2,338,047 |
| MILLENNIUM MANAGEMENT LLC | 5.8% | 1,617,531 | +51% | 0% | $1,417,281 |
| ACORN CAPITAL ADVISORS, LLC | 5.1% | 1,411,492 | -21% | 0.35% | $1,242,113 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4.9% | 1,352,106 | 0.2% | $1,184,715 | |
| MORGAN STANLEY | 4.8% | 1,333,420 | -32% | 0% | $1,168,343 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 1,172,597 | 0% | 0% | $1,027,195 |
| Rock Springs Capital Management LP | 4% | 1,100,726 | 0% | 0.06% | $964,456 |
| Carlyle Group Inc. | 3.8% | 1,066,189 | 0% | 0.01% | $934,195 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.1% | 582,751 | -27% | 0.01% | $510,606 |
| Lion Point Capital, LP | 1.7% | 465,000 | 0% | 2.4% | $407,433 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.2% | 322,273 | +488% | 0% | $282,376 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 317,677 | +50% | 0% | $278,394 |
| BANK OF AMERICA CORP /DE/ | 1.1% | 293,259 | +0.08% | 0% | $256,895 |
| Soleus Capital Management, L.P. | 0.99% | 276,312 | +38% | 0.01% | $242,105 |
| BlackRock, Inc. | 0.87% | 242,061 | +2.5% | 0% | $212,093 |
| RENAISSANCE TECHNOLOGIES LLC | 0.64% | 177,500 | -22% | 0% | $155,526 |
| Knott David M Jr | 0.58% | 160,789 | -11% | 0.08% | $140,883 |
| VANGUARD FIDUCIARY TRUST CO | 0.54% | 149,943 | 0% | 0% | $131,350 |
| ADAR1 Capital Management, LLC | 0.5% | 140,000 | 0% | 0.01% | $122,668 |
| Quarry LP | 0.47% | 131,529 | +32% | 0.02% | $115,246 |
| UBS Group AG | 0.29% | 81,117 | -36% | 0% | $71,058 |
| Verdad Advisers, LP | 0.27% | 73,967 | 0.07% | $64,810 | |
| Squarepoint Ops LLC | 0.23% | 64,915 | -77% | 0% | $56,879 |
| IEQ CAPITAL, LLC | 0.19% | 51,428 | +2% | 0% | $45,061 |
| MARSHALL WACE, LLP | 0.16% | 45,656 | 0% | $40,177 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Latest
Q1 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 15,813,140 | $13,860,993 | -$7,106,029 | $0.88 | 57 |
| 2025 Q4 | 19,220,734 | $35,163,686 | -$2,365,311 | $1.83 | 53 |
| 2025 Q3 | 20,155,363 | $47,814,871 | +$13,375,643 | $2.38 | 60 |
| 2025 Q2 | 12,514,434 | $69,456,410 | -$2,535,024 | $5.55 | 63 |
| 2025 Q1 | 13,034,173 | $56,047,183 | -$70,633,595 | $4.30 | 66 |
| 2024 Q4 | 15,646,434 | $334,368,683 | +$15,008,656 | $21.38 | 84 |
| 2024 Q3 | 14,676,954 | $274,620,688 | -$5,485,865 | $18.81 | 77 |
| 2024 Q2 | 14,557,013 | $329,580,756 | +$34,893,415 | $22.70 | 67 |
| 2024 Q1 | 12,950,959 | $379,146,145 | +$364,621,578 | $29.36 | 56 |
| 2023 Q4 | 494,706 | $390,323 | +$390,323 | $0.79 | 1 |